Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Live Feeds
Press Releases
Insider Trading
FDA Approvals
Analyst Ratings
Insider Trading
SEC filings
Market insights
Analyst Ratings
Alerts
Subscriptions
Settings
RSS Feeds
Publish
Dashboard
Subscribe to $ACTU
Actuate Therapeutics Inc.
Subscribe to $ACTU
$ACTU
Biotechnology: Pharmaceutical Preparations
Health Care
IPO Year: 2024
Exchange: NASDAQ
Recent Analyst Ratings for Actuate Therapeutics Inc.
Date
Price Target
Rating
Analyst
4/22/2025
$21.00
Buy
Craig Hallum
3/17/2025
$20.00
Buy
H.C. Wainwright
See more ratings
